430 related articles for article (PubMed ID: 17175037)
1. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
[TBL] [Abstract][Full Text] [Related]
2. Role of free fatty acids in regulating gastric emptying and gallbladder contraction.
Degen L; Matzinger D; Drewe J; Nisslé S; Maecke H; Lengsfeld H; Hadvary P; Beglinger C
Digestion; 2006; 74(3-4):131-9. PubMed ID: 17220631
[TBL] [Abstract][Full Text] [Related]
3. Influence of a lipase inhibitor on gastric sensitivity and accommodation to an orally ingested meal.
Demarchi B; Vos R; Deprez P; Janssens J; Tack J
Aliment Pharmacol Ther; 2004 Jun; 19(12):1261-8. PubMed ID: 15191507
[TBL] [Abstract][Full Text] [Related]
4. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
[TBL] [Abstract][Full Text] [Related]
5. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
[TBL] [Abstract][Full Text] [Related]
6. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal.
Goedecke JH; Barsdorf M; Beglinger C; Levitt NS; Lambert EV
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1479-85. PubMed ID: 14634678
[TBL] [Abstract][Full Text] [Related]
7. Influences of fat restriction and lipase inhibition on gastric emptying in obesity.
Mathus-Vliegen EM; van Ierland-van Leeuwen ML; Bennink RJ
Int J Obes (Lond); 2006 Aug; 30(8):1203-10. PubMed ID: 16462818
[TBL] [Abstract][Full Text] [Related]
8. Gallbladder emptying to endogenous and exogenous stimulation in chronic pancreatitis patients.
Meguro T; Shimosegawa T; Kashimura J; Kikuchi Y; Koizumi M; Toyota T
Am J Gastroenterol; 1994 Feb; 89(2):225-31. PubMed ID: 8304308
[TBL] [Abstract][Full Text] [Related]
9. Release of cholecystokinin and gallbladder contraction before and after gastrectomy.
Inoue K; Fuchigami A; Hosotani R; Kogire M; Huang YS; Miyashita T; Suzuki T; Tsuda K; Seino Y; Rayford PL
Ann Surg; 1987 Jan; 205(1):27-32. PubMed ID: 3800460
[TBL] [Abstract][Full Text] [Related]
10. Role of lipase in the regulation of upper gastrointestinal function in humans.
Schwizer W; Asal K; Kreiss C; Mettraux C; Borovicka J; Rémy B; Güzelhan C; Hartmann D; Fried M
Am J Physiol; 1997 Sep; 273(3 Pt 1):G612-20. PubMed ID: 9316463
[TBL] [Abstract][Full Text] [Related]
11. Orlistat inhibits dietary cholesterol absorption.
Mittendorfer B; Ostlund RE; Patterson BW; Klein S
Obes Res; 2001 Oct; 9(10):599-604. PubMed ID: 11595776
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine.
Portincasa P; Di Ciaula A; Palmieri VO; Baldassarre G; Palasciano G
Am J Gastroenterol; 1994 Jun; 89(6):909-14. PubMed ID: 8198104
[TBL] [Abstract][Full Text] [Related]
13. Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects.
O'Donovan D; Feinle-Bisset C; Wishart J; Horowitz M
Br J Nutr; 2003 Nov; 90(5):849-52. PubMed ID: 14667178
[TBL] [Abstract][Full Text] [Related]
14. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Bekkering M; Giacovelli G; D'Amato M; Rovati LC
Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
[TBL] [Abstract][Full Text] [Related]
15. Effect of rectal distension on gallbladder emptying and circulating gut hormones.
van Hoek F; Mollen RM; Hopman WP; Kuijpers HH; Jansen JB
Eur J Clin Invest; 2000 Nov; 30(11):988-94. PubMed ID: 11114961
[TBL] [Abstract][Full Text] [Related]
16. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
Otto B; Mawe GM; Riepl RL
Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
[TBL] [Abstract][Full Text] [Related]
17. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction.
Marciani L; Wickham M; Singh G; Bush D; Pick B; Cox E; Fillery-Travis A; Faulks R; Marsden C; Gowland PA; Spiller RC
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1607-13. PubMed ID: 17332474
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
Regan PT; Go VL; DiMagno EP
J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
[TBL] [Abstract][Full Text] [Related]
20. [Plasma cholecystokinin level in chronic pancreatitis].
Mössner J; Back T; Regner U; Fischbach W
Z Gastroenterol; 1989 Aug; 27(8):401-5. PubMed ID: 2609704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
